Samsara Therapeutics Inc. — Form D
Samsara Therapeutics Inc. of LEWES, DE, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-16. The offering totals $12.7M, of which $10.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-16
- Form: D
- Accession: 0001872991-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.7M
- Amount sold: $10.3M
- Remaining: $2.4M
- Investors: 17
- Date of first sale: 2021-07-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-406531
Issuer
- Name: Samsara Therapeutics Inc.
- CIK: 0001872991
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 16192 COASTAL HIGHWAY, LEWES, DE, 19958
- Phone: 617-413-8733
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Jens Eckstein | Director | Cambridge, MA |
| Jens Eckstein | Executive Officer | Cambridge, MA |
More